Chapter 12: Schizophrenia and Other Psychotic Disorders

The content traces diagnostic evolution from Kraepelin's conceptualization of dementia praecox through Bleuler's introduction of schizophrenia and identification of the Four A's as foundational features, to Schneider's delineation of first-rank symptoms including auditory hallucinations, thought insertion, thought withdrawal, and delusional perception. The chapter documents major transitions in diagnostic frameworks across successive editions of the Diagnostic and Statistical Manual, progressing from expansive definitions in DSM-II toward the symptom-specific and narrower approach established in DSM-III, culminating in contemporary DSM-5-TR and ICD-11 criteria that prioritize illness duration, functional decline, and dimensional rather than categorical subtyping. Key symptom clusters are systematically analyzed, encompassing positive symptoms such as delusions and hallucinations, negative symptoms including affective flattening and motivational deficits, and disorganized symptomatology, with standardized assessment tools like the Brief Psychiatric Rating Scale and Positive and Negative Syndrome Scale serving as essential instruments in clinical evaluation and research methodology. The chapter addresses cross-cultural phenomenology, illustrating both universal and culturally specific patterns in psychotic presentations. Neurobiological frameworks are presented, with particular attention to the dopamine hypothesis of psychosis and emerging understanding of cognitive processes and neural networks underlying clinical expression. Treatment approaches are presented as integrative and multifaceted, incorporating antipsychotic pharmacotherapy alongside evidence-based psychosocial interventions, family psychoeducation, cognitive remediation strategies, and comprehensive service delivery models including the RAISE program. The chapter introduces contemporary research paradigms such as the Research Domain Criteria framework, promoting movement toward biologically informed nosology and individualized treatment planning. Throughout, schizophrenia is framed as a complex neurobiological condition requiring scientifically grounded, compassionate, and person-centered clinical approaches.